GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Breast Cancer Research and Treatment, Springer Science and Business Media LLC, Vol. 172, No. 1 ( 2018-11), p. 209-219
    Type of Medium: Online Resource
    ISSN: 0167-6806 , 1573-7217
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2018
    detail.hit.zdb_id: 2004077-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2020
    In:  Cancer Epidemiology, Biomarkers & Prevention Vol. 29, No. 6_Supplement_1 ( 2020-06-01), p. C087-C087
    In: Cancer Epidemiology, Biomarkers & Prevention, American Association for Cancer Research (AACR), Vol. 29, No. 6_Supplement_1 ( 2020-06-01), p. C087-C087
    Abstract: Background: Estrogen receptor-negative (ERN) breast cancer is an early-stage, more aggressive breast cancer subtype. ERN breast cancer incidence is highest in African American women compared with other races, as well as in southern US regions. However, recent studies have shown that ERN breast cancer incidence is declining for women overall. We sought to understand whether ERN breast cancer is declining similarly in all races, age groups, and SEER registries. Methods: Data from Surveillance, Epidemiology, and End-Results (SEER) Program 13 registries from 1990-2014, as well as the remaining five SEER 18 registries from 2000-2014, were used to observe ERN breast cancer incidence rates among non-Hispanic white (NHW) and non-Hispanic black (NHB) women by age group (30-39, 40-49, 50-69, 70-84 years). Age-period-cohort modeling was used and extended, allowing for regional heterogeneity by population (i.e. SEER registry), to estimate differences in longitudinal age trends and net drifts by race and SEER registry. Results: Among all age groups within all SEER 18 registries, ERN breast cancer incidence rates were higher for NHB compared to NHW women. Furthermore, ERN rates have been decreasing for both NHW and NHB women. For the entire SEER population, women ages 40-49 years compared to other age groups demonstrated the fastest declines in ERN breast cancer incidence, with a net drift of -3.5%/year (95% CI: -4.0, -3.1) for NHW women, and -3.1%/year (-3.8, -2.2) for NHB women. Among the youngest women (30-39 years), ERN rates have declined faster in NHB compared to NHW women, with net drifts of -2.7%/year (-3.5, -1.8) and -1.7%/year (-2.2, -1.2), respectively; for all other age groups, rates have declined faster for NHW compared to NHB women. For NHW women of all age groups, there was relatively little between-registry variability in trends, with net drift standard deviations of 0.5%/year (0.02, 1.3) for 30-39 years, 0.8%/year (0.4, 1.2) for 40-49 years, 0.6%/year (0.4, 0.9) for 50-69 years, and 0.7%/year (0.4, 1.1) for 70-84 years. For NHB women, rates have also decreased similarly across registries in the youngest age group (30-39 years), with between-registry net drift standard deviation of 0.4%/year (0.01, 1.5); however, for NHB of all other age groups, there was more between-registry variability with net drift standard deviations of 1.0%/year (0.1, 2.1) for 40-49 years, 1.0%/year (0.4, 1.8) for 50-59 years, and 1.2%/year (0.4, 2.4) for 70-84 years. These standard deviations reflect that ERN rates have been declining more slowly in southern registries (i.e., Greater Georgia, Atlanta, Rural Georgia, and Louisiana) for older NHB women. Conclusion: Among NHW women, decreases in ERN breast cancer incidence have been similar across age groups and SEER registries. Among NHB women, ERN rates have also been decreasing; however, these decreases vary by age and SEER registry, which may offer etiologic clues. Further investigation is needed to understand which factors are contributing to these trends. Citation Format: Brittny C. Davis Lynn, Pavel Chernyavskiy, William F. Anderson, Gretchen L. Gierach, Philip S. Rosenberg. Differences in estrogen receptor-negative breast cancer by race and SEER registry [abstract] . In: Proceedings of the Eleventh AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2018 Nov 2-5; New Orleans, LA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl):Abstract nr C087.
    Type of Medium: Online Resource
    ISSN: 1055-9965 , 1538-7755
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2020
    detail.hit.zdb_id: 2036781-8
    detail.hit.zdb_id: 1153420-5
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Breast Cancer Research, Springer Science and Business Media LLC, Vol. 24, No. 1 ( 2022-12-05)
    Abstract: Terminal duct lobular units (TDLUs) are the structures in the breast that give rise to most breast cancers. Previous work has shown that TDLU involution is inversely associated with TDLU metrics, such as TDLU count/100mm 2 , TDLU span (µm), and number of acini/TDLU, and that these metrics may be elevated in the normal breast tissue of women diagnosed with triple-negative (TN) compared with luminal A breast tumors. It is unknown whether this relationship exists in Black women, who have the highest incidence of TN breast cancer and the highest overall breast cancer mortality rate. We examined relationships between TDLU metrics and breast cancer molecular subtype among breast cancer cases in the Black Women’s Health Study (BWHS). Methods We assessed quantitative TDLU metrics (TDLU count/100mm 2 , TDLU span (µm), and number of acini/TDLU) in digitized 247 hematoxylin and eosin-stained adjacent normal tissue sections from 223 BWHS breast cancer cases, including 65 triple negative (TN) cancers (estrogen receptor (ER) negative, progesterone receptor (PR) negative, human epidermal growth factor-2 (HER2) negative) and 158 luminal A cancers (ER positive, HER2 negative). We evaluated associations of least square mean TDLU metrics adjusted for age and body mass index (BMI) with patient and clinical characteristics. In logistic regression models, we evaluated associations between TDLU metrics and breast cancer subtype, adjusting for age, BMI, and tumor size. Results Older age and higher BMI were associated with lower TDLU metrics and larger tumor size and lymph node invasion with higher TDLU metrics. The odds of TN compared with luminal A breast cancer increased with increasing tertiles of TDLU metrics, with odds ratios (95% confidence intervals) for tertile 3 versus tertile 1 of 2.18 (0.99, 4.79), 2.77 (1.07, 7.16), and 1.77 (0.79, 3.98) for TDLU count, TDLU span, and acini count/TDLU, respectively. Conclusion Associations of TDLU metrics with breast cancer subtypes in the BWHS are consistent with previous studies of White and Asian women, demonstrating reduced TDLU involution in TN compared with luminal A breast cancers. Further investigation is needed to understand the factors that influence TDLU involution and the mechanisms that mediate TDLU involution and breast cancer subtype.
    Type of Medium: Online Resource
    ISSN: 1465-542X
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 2041618-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Breast Cancer Research, Springer Science and Business Media LLC, Vol. 23, No. 1 ( 2021-12)
    Abstract: Estimates of contralateral breast cancer (CBC) risk in the modern treatment era by year of diagnosis and characteristics of the first breast cancer are needed to assess the impact of recent advances in breast cancer treatment and inform clinical decision making. Methods We examined CBC risk among 419,818 women (age 30–84 years) who were diagnosed with a first unilateral invasive breast cancer and survived ≥ 1 year in the US Surveillance, Epidemiology, and End Results program cancer registries from 1992 to 2015 (follow-up through 2016). CBC was defined as a second invasive breast cancer in the contralateral breast ≥ 12 months after the first breast cancer. We estimated standardized incidence ratios (SIRs) of CBC by year of diagnosis, age at diagnosis, and tumor characteristics for the first breast cancer. Cumulative incidence of CBC was calculated for women diagnosed with a first breast cancer in the recent treatment era (2004–2015, follow-up through 2016). Results Over a median follow-up of 8 years (range 1–25 years), 12,986 breast cancer patients developed CBC. Overall, breast cancer patients had approximately twice the risk of developing cancer in the contralateral breast when compared to that expected in the general population (SIR = 2.21, 95% CI = 2.17–2.25). SIRs for CBC declined by year of first diagnosis, irrespective of age at diagnosis and estrogen receptor (ER) status ( p -trends 〈  0.001), but the strongest decline was after an ER-positive tumor. The 5-year cumulative incidence of CBC ranged from 1.01% (95% CI = 0.90–1.14%) in younger women (age  〈  50 years) with a first ER-positive tumor to 1.89% (95% CI = 1.61–2.21%) in younger women with a first ER-negative tumor. Conclusion Declines in CBC risk are consistent with continued advances in breast cancer treatment. The updated estimates of cumulative incidence inform breast cancer patients and clinicians on the risk of CBC and may help guide treatment decisions.
    Type of Medium: Online Resource
    ISSN: 1465-542X
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2021
    detail.hit.zdb_id: 2041618-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Cancer Prevention Research, American Association for Cancer Research (AACR), Vol. 12, No. 11 ( 2019-11-01), p. 781-790
    Abstract: Black women in the United States are disproportionately affected by early-onset, triple-negative breast cancer. DNA methylation has shown differences by race in healthy and tumor breast tissues. We examined associations between genome-wide DNA methylation levels in breast milk and breast cancer risk factors, including race, to explain how this reproductive stage influences a woman's risk for, and potentially contributes to racial disparities in, breast cancer. Breast milk samples and demographic, behavioral, and reproductive data, were obtained from cancer-free, uniparous, and lactating U.S. black (n = 57) and white (n = 82) women, ages 19–44. Genome-wide DNA methylation analysis was performed on extracted breast milk DNA using the Infinium HumanMethylation450 BeadChip. Statistically significant associations between breast cancer risk factors and DNA methylation beta values, adjusting for potential confounders, were determined using linear regression followed by Bonferroni Correction (P & lt; 1.63 × 10−7). Epigenetic analysis in breast milk revealed statistically significant associations with race and lactation duration. Of the 284 CpG sites associated with race, 242 were hypermethylated in black women. All 227 CpG sites associated with lactation duration were hypomethylated in women who lactated longer. Ingenuity Pathway Analysis of differentially methylated promoter region CpGs by race and lactation duration revealed enrichment for networks implicated in carcinogenesis. Associations between DNA methylation and lactation duration may offer insight on its role in lowering breast cancer risk. Epigenetic associations with race may mediate social, behavioral, or other factors related to breast cancer and may provide insight into potential mechanisms underlying racial disparities in breast cancer incidence.
    Type of Medium: Online Resource
    ISSN: 1940-6207 , 1940-6215
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2019
    detail.hit.zdb_id: 2422346-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...